Locations:
Search
Patient history plays a key role in identifying the condition
Specificity in study criteria yields sleep disorder insights
A co-author explains some of the key McDonald criteria revisions
The BTK inhibitor tolebrutinib meets its primary endpoint in phase 3 HERCULES trial
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Meaningful characterization is critical to advancing research and care, review authors contend
Guidance from international committee on differential diagnoses and diagnostic approach
Investigational gene approaches offer hope for a therapeutically challenging condition
$3.2 million grant will fund use of calcium-based imaging to record neuronal activity in ischemia model
Findings from large cohort analysis can guide ongoing quality improvement initiatives
New phase 1 trial showcases Neurological Institute’s interdisciplinary study capabilities
Advertisement
Advertisement